Literature DB >> 22218932

Persistently low intact parathyroid hormone levels predict a progression of aortic arch calcification in incident hemodialysis patients.

Harin Rhee1, Sang Heon Song, Ihm Soo Kwak, Soo Bong Lee, Dong Won Lee, Eun Young Seong, Il Young Kim.   

Abstract

BACKGROUND: Recent observational studies have found that low intact parathyroid hormone (iPTH) is related with mortality in hemodialysis patients and these findings may be considered to be the result of accelerated cardiovascular calcifications in adynamic bone disease. This study was aimed to determine the relationship between persistently low iPTH and aortic arch calcification (AAC) in incident hemodialysis patients.
METHODS: From January 2004 to December 2008, a total of 94 incident hemodialysis patients were enrolled in this study. They were divided into three groups according to the changing patterns of iPTH during the first year of hemodialysis. ACC was scored on posterior-anterior plain chest X-rays using a specific scale at the initiation of dialysis and followed till May 2011.
RESULTS: The median follow-up periods were 46.9 months. The prevalence of baseline AAC and its progression were the highest in the persistently low iPTH group. Also, all-cause mortality was the highest in this group. Age, baseline calcification score and persistently low iPTH independently contributed to the progression of calcification by multivariate logistic regression analyses (HR 1.083, 95% CI 1.023-1.147, P = 0.006; HR 3.320, 95% CI 1.023-10.789, P = 0.046; HR 5.207, 95% CI 1.027-26.412, P = 0.046, respectively). Also, mortality was relatively higher in calcification progressor compared to non-progressor (39.3, 18.2%, P = 0.030).
CONCLUSION: Persistently low iPTH was an independent risk factor for both AAC and mortality in incident hemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22218932     DOI: 10.1007/s10157-011-0577-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  31 in total

1.  K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2003-10       Impact factor: 8.860

2.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

3.  Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders.

Authors:  Andrea Galassi; David M Spiegel; Antonio Bellasi; Geoffrey A Block; Paolo Raggi
Journal:  Nephrol Dial Transplant       Date:  2006-07-28       Impact factor: 5.992

Review 4.  Insights into nutritional and inflammatory aspects of low parathyroid hormone in dialysis patients.

Authors:  Usama Feroze; Miklos Z Molnar; Ramanath Dukkipati; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

5.  Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

Authors:  P Stenvinkel; O Heimbürger; F Paultre; U Diczfalusy; T Wang; L Berglund; T Jogestrand
Journal:  Kidney Int       Date:  1999-05       Impact factor: 10.612

Review 6.  Vascular calcifications: pathogenesis, management, and impact on clinical outcomes.

Authors:  Jorge B Cannata-Andía; Minerva Rodríguez-García; Natalia Carrillo-López; Manuel Naves-Díaz; Bernardino Díaz-López
Journal:  J Am Soc Nephrol       Date:  2006-12       Impact factor: 10.121

7.  Evidence for abnormal calcium homeostasis in patients with adynamic bone disease.

Authors:  P Kurz; M C Monier-Faugere; B Bognar; E Werner; P Roth; J Vlachojannis; H H Malluche
Journal:  Kidney Int       Date:  1994-09       Impact factor: 10.612

8.  Simple evaluation of aortic arch calcification by chest radiography in hemodialysis patients.

Authors:  Tetsuya Ogawa; Hideki Ishida; Nami Matsuda; Ayuko Fujiu; Akiko Matsuda; Kyoko Ito; Yoshitaka Ando; Kosaku Nitta
Journal:  Hemodial Int       Date:  2009-05-27       Impact factor: 1.812

Review 9.  Paricalcitol and outcome: a manual on how a vitamin D receptor activator (VDRA) can help us to get down the "U".

Authors:  M Cozzolino; V Brandenburg
Journal:  Clin Nephrol       Date:  2009-06       Impact factor: 0.975

Review 10.  CKD-MBD: impact on management of kidney disease.

Authors:  Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa
Journal:  Clin Exp Nephrol       Date:  2007-12-21       Impact factor: 2.801

View more
  4 in total

1.  Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism.

Authors:  Yue Yu; Zongli Diao; Ying Wang; Peiyi Zhou; Rui Ding; Wenhu Liu
Journal:  Ther Adv Endocrinol Metab       Date:  2020-09-21       Impact factor: 3.565

2.  (18)F-fluoride positron emission tomography measurements of regional bone formation in hemodialysis patients with suspected adynamic bone disease.

Authors:  Michelle L Frost; Juliet E Compston; David Goldsmith; Amelia E Moore; Glen M Blake; Musib Siddique; Linda Skingle; Ignac Fogelman
Journal:  Calcif Tissue Int       Date:  2013-08-31       Impact factor: 4.333

3.  Impact of Different Levels of iPTH on All-Cause Mortality in Dialysis Patients with Secondary Hyperparathyroidism after Parathyroidectomy.

Authors:  Qiu Ping Xi; Xi Sheng Xie; Ling Zhang; Rui Zhang; Yue Fei Xiao; Cheng Gang Jin; Yan Bo Li; Lin Wang; Xiao Xuan Zhang; Shu Tong Du
Journal:  Biomed Res Int       Date:  2017-06-05       Impact factor: 3.411

4.  Relationship between serum parathyroid hormone levels and abdominal aortic calcification in patients starting hemodialysis who have never taken calcium tablets, calcitriol, or vitamin D analogs.

Authors:  Jin He; Xiaoyan Sun; Rongjian Nie; Lin Zhao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.